Influenza vaccination in the elderly

Area of Science:

• Gerontology
• Immunology
• Vaccinology

Background:

• Influenza vaccination is recommended for individuals aged 65 and older.
• Elderly individuals may exhibit reduced antibody production post-vaccination compared to younger adults.
• Existing influenza vaccine formulations include whole virus, split virus, and subunit vaccines.

Purpose of the Study:

• To evaluate the efficacy and safety of influenza vaccination in the elderly population.
• To compare the immunogenicity and protective effects of different influenza vaccine types in older adults.
• To inform current vaccination policies for the elderly and at-risk groups.

Main Methods:

• Review of studies investigating influenza vaccine types (whole virus, split, subunit, live attenuated, virosomal) in elderly populations.
• Analysis of serological responses and clinical protection data, including hospitalization rates.
• Assessment of vaccine tolerance and adverse events in higher age group vaccinees.

Main Results:

• Influenza vaccines are well-tolerated in the elderly.
• Clinical protection against hospitalization is demonstrated to be greater than or equal to 50%.
• Live attenuated influenza vaccines show protection comparable to conventional subunit vaccines; virosomal vaccines show promising serological results.

Conclusions:

• Influenza vaccination is a valuable intervention for protecting the elderly against severe outcomes.
• Current vaccination policies targeting individuals aged 65+ and their close contacts are supported by evidence.
• Annual vaccination with updated strains is crucial for effective influenza prevention in older adults.